US Stock MarketDetailed Quotes

CYCN Cyclerion Therapeutics

Watchlist
  • 2.5650
  • -0.0650-2.47%
Close Mar 11 16:00 ET
  • 2.5650
  • 0.00000.00%
Post 16:00 ET
6.95MMarket Cap-2.12P/E (TTM)

Cyclerion Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
79.60%-4.33M
123.36%360K
75.26%-1.72M
83.13%-1.11M
69.89%-1.87M
47.69%-21.25M
78.12%-1.54M
30.06%-6.94M
39.41%-6.56M
51.59%-6.21M
Net income from continuing operations
41.92%-3.06M
131.29%530K
-109.56%-723K
68.38%-1.32M
77.83%-1.54M
88.06%-5.26M
76.52%-1.69M
172.08%7.57M
68.77%-4.18M
46.42%-6.95M
Other non cash items
97.70%-363K
--0
----
----
----
---15.75M
--0
----
----
----
Change In working capital
66.57%-1.54M
-684.00%-292K
65.28%-768K
101.16%32K
-262.42%-510K
-61.44%-4.6M
105.26%50K
-104.63%-2.21M
-422.37%-2.75M
118.78%314K
-Change in receivables
-679.17%-556K
---512K
---44K
----
----
2,300.00%96K
--0
--0
----
----
-Change in prepaid assets
-94.21%21K
-29.58%200K
-258.81%-505K
140.25%192K
-43.70%134K
195.12%363K
205.58%284K
186.49%318K
-232.50%-477K
401.27%238K
-Change in payables and accrued expense
81.99%-998K
109.80%25K
91.60%-219K
93.81%-160K
-570.83%-644K
-60.24%-5.54M
71.73%-255K
-96.98%-2.61M
-815.79%-2.58M
93.98%-96K
-Change in other current assets
-101.04%-5K
-123.81%-5K
--0
--0
--0
0.00%481K
-76.40%21K
-41.98%76K
59.40%212K
34.38%172K
Cash from discontinued investing activities
Operating cash flow
79.60%-4.33M
123.36%360K
75.26%-1.72M
83.13%-1.11M
69.89%-1.87M
47.69%-21.25M
78.12%-1.54M
30.06%-6.94M
39.41%-6.56M
51.59%-6.21M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
----
----
--10.4M
--0
--10.4M
----
----
Financing cash flow
Cash flow from continuing financing activities
0
0
0
17,224.14%5.02M
0
0
Net common stock issuance
----
----
--0
----
----
----
----
--0
----
----
Proceeds from stock option exercised by employees
--0
--0
--0
----
----
17,224.14%5.02M
41,566.67%5M
--0
----
----
Cash from discontinued financing activities
Financing cash flow
--0
--0
--0
----
----
17,224.14%5.02M
--0
--0
----
----
Net cash flow
Beginning cash position
-43.42%7.57M
-68.47%2.87M
-18.67%4.59M
-20.55%5.7M
-43.42%7.57M
-75.20%13.38M
-55.36%9.11M
-81.40%5.64M
-82.57%7.17M
-75.20%13.38M
Current changes in cash
25.54%-4.33M
123.36%360K
-149.50%-1.72M
27.76%-1.11M
69.89%-1.87M
85.66%-5.82M
78.08%-1.54M
134.97%3.47M
85.83%-1.53M
51.59%-6.21M
Effect of exchange rate changes
-175.00%-6K
--0
--0
-166.67%-2K
-500.00%-4K
166.67%8K
-50.00%4K
--0
400.00%3K
200.00%1K
End cash Position
-57.31%3.23M
-57.31%3.23M
-68.47%2.87M
-18.67%4.59M
-20.55%5.7M
-43.42%7.57M
-43.42%7.57M
-55.36%9.11M
-81.40%5.64M
-82.57%7.17M
Free cash flow
79.60%-4.33M
123.36%360K
75.26%-1.72M
83.13%-1.11M
69.89%-1.87M
47.69%-21.25M
78.12%-1.54M
30.06%-6.94M
39.41%-6.56M
51.59%-6.21M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 79.60%-4.33M123.36%360K75.26%-1.72M83.13%-1.11M69.89%-1.87M47.69%-21.25M78.12%-1.54M30.06%-6.94M39.41%-6.56M51.59%-6.21M
Net income from continuing operations 41.92%-3.06M131.29%530K-109.56%-723K68.38%-1.32M77.83%-1.54M88.06%-5.26M76.52%-1.69M172.08%7.57M68.77%-4.18M46.42%-6.95M
Other non cash items 97.70%-363K--0---------------15.75M--0------------
Change In working capital 66.57%-1.54M-684.00%-292K65.28%-768K101.16%32K-262.42%-510K-61.44%-4.6M105.26%50K-104.63%-2.21M-422.37%-2.75M118.78%314K
-Change in receivables -679.17%-556K---512K---44K--------2,300.00%96K--0--0--------
-Change in prepaid assets -94.21%21K-29.58%200K-258.81%-505K140.25%192K-43.70%134K195.12%363K205.58%284K186.49%318K-232.50%-477K401.27%238K
-Change in payables and accrued expense 81.99%-998K109.80%25K91.60%-219K93.81%-160K-570.83%-644K-60.24%-5.54M71.73%-255K-96.98%-2.61M-815.79%-2.58M93.98%-96K
-Change in other current assets -101.04%-5K-123.81%-5K--0--0--00.00%481K-76.40%21K-41.98%76K59.40%212K34.38%172K
Cash from discontinued investing activities
Operating cash flow 79.60%-4.33M123.36%360K75.26%-1.72M83.13%-1.11M69.89%-1.87M47.69%-21.25M78.12%-1.54M30.06%-6.94M39.41%-6.56M51.59%-6.21M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Investing cash flow --0--0--0----------10.4M--0--10.4M--------
Financing cash flow
Cash flow from continuing financing activities 00017,224.14%5.02M00
Net common stock issuance ----------0------------------0--------
Proceeds from stock option exercised by employees --0--0--0--------17,224.14%5.02M41,566.67%5M--0--------
Cash from discontinued financing activities
Financing cash flow --0--0--0--------17,224.14%5.02M--0--0--------
Net cash flow
Beginning cash position -43.42%7.57M-68.47%2.87M-18.67%4.59M-20.55%5.7M-43.42%7.57M-75.20%13.38M-55.36%9.11M-81.40%5.64M-82.57%7.17M-75.20%13.38M
Current changes in cash 25.54%-4.33M123.36%360K-149.50%-1.72M27.76%-1.11M69.89%-1.87M85.66%-5.82M78.08%-1.54M134.97%3.47M85.83%-1.53M51.59%-6.21M
Effect of exchange rate changes -175.00%-6K--0--0-166.67%-2K-500.00%-4K166.67%8K-50.00%4K--0400.00%3K200.00%1K
End cash Position -57.31%3.23M-57.31%3.23M-68.47%2.87M-18.67%4.59M-20.55%5.7M-43.42%7.57M-43.42%7.57M-55.36%9.11M-81.40%5.64M-82.57%7.17M
Free cash flow 79.60%-4.33M123.36%360K75.26%-1.72M83.13%-1.11M69.89%-1.87M47.69%-21.25M78.12%-1.54M30.06%-6.94M39.41%-6.56M51.59%-6.21M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Strategy
MSTR
+8.91%
Coinbase
COIN
+6.95%
Tesla
TSLA
+3.79%
Vale SA
VALE
+1.73%
Salesforce
CRM
+1.52%

Unlock the Full List